MAPLE GROVE, Minn. – Upsher-Smith Laboratories announced the recent launch of methimazole tablets, USP, 5 mg and

10 mg. The methimazole tablet market had U.S. sales of approximately $36.8 million for the 12 months ending December 2023 according to IQVIA. The Therapeutic Equivalence (TE) code for the product is AB, and the original Reference Listed Drug (RLD) was the brand Tapazole.